Literature DB >> 30768677

Characterising the risk of Hepatitis E virus infection in haematological malignancies: a UK prospective prevalence study.

Michael J Ankcorn1,2, Thomas A Fox3, Samreen Ijaz1, Claire Nicholas3, Eric Houston3, Ian Longair3, Deepak Suri4, Frank M Mattes5, Jemma L Walker6,7, Richard S Tedder1,2,8, Mallika Sekhar3,9,10.   

Abstract

Entities:  

Keywords:  haematological malignancy; hepatitis E virus; immunocompromised; multiple myeloma; screening

Mesh：

Year:  2019        PMID： 30768677     DOI： 10.1111/bjh.15796

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study.

Authors:  Hatice Yasemin Balaban; Abdullah Tarık Aslan; Fatma Nur Akdoğan-Kittana; Alpaslan Alp; Osman Dağ; Şefika Nur Ayar; Cavanşir Vahabov; Cem Şimşek; Tolga Yıldırım; Hakan Göker; Koray Ergünay; Yunus Erdem; Yahya Büyükaşık; Halis Şimşek
Journal:  Turk J Gastroenterol       Date:  2022-07       Impact factor: 1.555

Review 2.  Transfusion-transmitted hepatitis E: What we know so far?

Authors:  Carmen Ka Man Cheung; Sunny Hei Wong; Alvin Wing Hin Law; Man Fai Law
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

3.  Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for Difficult-To-Treat Chronic Hepatitis E.

Authors:  Marten Schulz; Paula Biedermann; Claus-Thomas Bock; Jörg Hofmann; Mira Choi; Frank Tacke; Leif Gunnar Hanitsch; Tobias Mueller
Journal:  Int J Environ Res Public Health       Date:  2020-01-03       Impact factor: 3.390
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.